Early trial results suggest the personalised vaccines prime the body to stop the deadly disease coming back. Only a quarter of patients survive for a year or more after pancreatic cancer diagnosis.
Cutting age vaccine for pancreatic cancer has been hailed by experts after trial. Results suggest personalised vaccines could stop deadly disease returning.
Quarter of pancreatic cancer patients survive over a year as T cells not active. 8 participants had cells recognise disease and remain cancer-free 18 months on
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: